Transaction Details

Footnotes

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.485 to $31.305 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | Non-qualified stock option portion of the 2024 annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant vested on June 6, 2025, the one-year anniversary of the grant date. | Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 13, 2023.